Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older
Toomey C, Muzikanksy A, Lee A, Barnes J, Michaelson J, Abramson J, Hochberg E. Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older. Blood 2010, 116: 733. DOI: 10.1182/blood.v116.21.733.733.Peer-Reviewed Original ResearchDiffuse large B-cell lymphomaCharlson Comorbidity IndexPatients age 75Patients 75 yearsUse of anthracyclinesComorbidity indexAge 75Elderly patientsOverall survivalPerformance statusPrognostic factorsSpeakers bureauModern chemotherapyAdvanced stageMedian Charlson comorbidity indexOutcome of DLBCLDiagnosis of DLBCLDischarge summariesLarge B-cell lymphomaExtranodal disease sitesHealth-related comorbiditiesECOG performance statusMedian overall survivalPatients 80 yearsAnn Arbor stage